Sea Mild Biotechnology Co (ROCO:7516) ROC (Joel Greenblatt) %: 8.89% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7516 Sea Mild Biotechnology Co Ltd ROCO:7516
74 GF Score
Price NT$8.65
GF Value NT$13.93
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Sea Mild Biotechnology Co ROC (Joel Greenblatt) %?

Sea Mild Biotechnology Co ROCO:7516 -0.57% 74 ROC (Joel Greenblatt) % is 8.89% as of Dec. 2025. GuruFocus rates ROCO:7516 with a GF Score™ of 74/100 and a GF Value™ of NT$13.93 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,979 Consumer Packaged Goods companies, Sea Mild Biotechnology Co ranks worse than 50.23% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Sea Mild Biotechnology Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 8.89%.

The historical rank and industry rank for Sea Mild Biotechnology Co's ROC (Joel Greenblatt) % or its related term are showing as below:

ROCO:7516' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -112.21   Med: -11   Max: 66.84
Current: 11.96

During the past 12 years, Sea Mild Biotechnology Co's highest ROC (Joel Greenblatt) % was 66.84%. The lowest was -112.21%. And the median was -11.00%.

ROCO:7516's ROC (Joel Greenblatt) % is ranked worse than
50.23% of 1979 companies
in the Consumer Packaged Goods industry
Industry Median: 11.99 vs ROCO:7516: 11.96

Sea Mild Biotechnology Co's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Sea Mild Biotechnology Co  (ROCO:7516) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Sea Mild Biotechnology Co ROC (Joel Greenblatt) % Related Terms


Sea Mild Biotechnology Co ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Sea Mild Biotechnology Co's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sea Mild Biotechnology Co ROC (Joel Greenblatt) % Chart

Sea Mild Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -54.47 -47.93 19.43 66.84 12.54

Sea Mild Biotechnology Co Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.52 59.45 54.96 15.46 8.89

ROCO:7516 vs PG, CL, KVUE: ROC (Joel Greenblatt) % Comparison

For the Household & Personal Products subindustry, Sea Mild Biotechnology Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sea Mild Biotechnology Co ROC (Joel Greenblatt) % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Sea Mild Biotechnology Co's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Sea Mild Biotechnology Co's ROC (Joel Greenblatt) % falls into.


ROCO:7516
74GF Score
Sea Mild Biotechnology Co Ltd ROCO:7516
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sea Mild Biotechnology Co ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(82.749 + 51.206 + 3.372) - (65.869 + 0 + 10.65)
=60.808

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(73.578 + 68.19 + 10.575) - (86.527 + 0 + 5.984)
=59.832

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Sea Mild Biotechnology Co for the quarter that ended in Dec. 2025 can be restated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=9.86/( ( (42.092 + max(60.808, 0)) + (58.974 + max(59.832, 0)) )/ 2 )
=9.86/( ( 102.9 + 118.806 )/ 2 )
=9.86/110.853
=8.89 %

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 8.89% mean?
Sea Mild Biotechnology Co (ROCO:7516) has a ROC (Joel Greenblatt) % of 8.89% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Sea Mild Biotechnology Co and its competitors. According to the industry distribution chart, Sea Mild Biotechnology Co ranks #994 out of 1979 companies in the Consumer Packaged Goods industry, placing it in the top 50.2%.
Is Sea Mild Biotechnology Co's ROC (Joel Greenblatt) % too high?
Sea Mild Biotechnology Co's current ROC (Joel Greenblatt) % is 8.89%. The Consumer Packaged Goods industry median ROC (Joel Greenblatt) % is 11.99. Sea Mild Biotechnology Co's value of 8.89% is 25.9% below this industry median. Based on the distribution chart, Sea Mild Biotechnology Co ranks #994 out of 1979 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Sea Mild Biotechnology Co has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sea Mild Biotechnology Co's ROC (Joel Greenblatt) % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Sea Mild Biotechnology Co ranks #994 out of 1979 companies for ROC (Joel Greenblatt) %. This places Sea Mild Biotechnology Co in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 11.99. Sea Mild Biotechnology Co's value of 8.89% is 25.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Consumer Packaged Goods company?
The median ROC (Joel Greenblatt) % among Consumer Packaged Goods companies is 11.99, based on 1,979 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sea Mild Biotechnology Co's current ROC (Joel Greenblatt) % of 8.89% is 25.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Sea Mild Biotechnology Co and its competitors. For the Consumer Packaged Goods industry, the median ROC (Joel Greenblatt) % is 11.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sea Mild Biotechnology Co's current ROC (Joel Greenblatt) % is 8.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sea Mild Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Sea Mild Biotechnology Co (ROCO:7516) is currently considered Possible Value Trap. The stock's GF Value™ is NT$13.93, compared to a current price of NT$8.65 — trading 37.9% below its estimated fair value. The current ROC (Joel Greenblatt) % is 8.89% and 25.9% below the Consumer Packaged Goods industry median of 11.99. Sea Mild Biotechnology Co's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Sea Mild Biotechnology Co (ROCO:7516), the current ROC (Joel Greenblatt) % is 8.89% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sea Mild Biotechnology Co (ROCO:7516) Overvalued in 2026?

Based on GuruFocus' analysis, Sea Mild Biotechnology Co stock appears to be undervalued. The current stock price of NT$8.65 is trading 37.9% below its estimated GF Value™ of NT$13.93. GuruFocus considers Sea Mild Biotechnology Co to be Possible Value Trap.

Key valuation signals for ROCO:7516:

  • ROC (Joel Greenblatt) %: 8.89%
  • GF Value™: NT$13.93 vs. price of NT$8.65 (37.9% below fair value)
  • GF Score™: 74/100 with 4 warning signs
  • Industry Position: 25.9% below the Consumer Packaged Goods median (#994 of 1979)

No single metric tells the full story. See the ROCO:7516 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sea Mild Biotechnology Co Business Description

Address 2nd Floor, No.89, Sector 2, Jianguo North Road, Zhongshan District, Taipei, TWN, 10479
Sea Mild Biotechnology Co Ltd is a manufacturer and distributor of household products. The company's products portfolio includes washing powder, laundry detergent, home cleaning products, personal cleaning and care products, and shampoo.
74GF Score

Get the complete analysis for ROCO:7516

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$8.65
Price
NT$13.93
GF Value